Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Butler

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Psychiatric Research and Clinical Practice|June 23, 2025
The Future of the PsychiatristJames B Potash, Alex McClanahan, Jay Davidson, et al.
Oncogene|January 20, 2022
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancerLingfan Xu, Bing Zhao, William Butler, et al.
The Journal of Clinical Investigation|December 15, 2023
Active DHEA uptake in the prostate gland correlates with aggressive prostate cancerXuebin Zhang, Zengming Wang, Shengsong Huang, et al.
Neurosurgery|August 11, 2016
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle StudyAdam M Sonabend, Brad E Zacharia, Michael B Cloney, et al.
Science Translational Medicine|December 6, 2019
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Yiping He, William Butler, et al.
Nature Neuroscience|February 24, 2025
PTEN mutations impair CSF dynamics and cortical networks by dysregulating periventricular neural progenitorsTyrone DeSpenza, Emre Kiziltug, Garrett Allington, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Psychiatric Research and Clinical Practice|June 23, 2025
The Future of the PsychiatristJames B Potash, Alex McClanahan, Jay Davidson, et al.
Oncogene|January 20, 2022
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancerLingfan Xu, Bing Zhao, William Butler, et al.
The Journal of Clinical Investigation|December 15, 2023
Active DHEA uptake in the prostate gland correlates with aggressive prostate cancerXuebin Zhang, Zengming Wang, Shengsong Huang, et al.
Neurosurgery|August 11, 2016
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle StudyAdam M Sonabend, Brad E Zacharia, Michael B Cloney, et al.
Science Translational Medicine|December 6, 2019
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Yiping He, William Butler, et al.
Nature Neuroscience|February 24, 2025
PTEN mutations impair CSF dynamics and cortical networks by dysregulating periventricular neural progenitorsTyrone DeSpenza, Emre Kiziltug, Garrett Allington, et al.
Pageof 6